株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

糖尿病性網膜症の世界市場:市場規模・現状・将来予測

Global Diabetic Retinopathy Market Size, Status and Forecast 2019-2025

発行 QYResearch 商品コード 843479
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
糖尿病性網膜症の世界市場:市場規模・現状・将来予測 Global Diabetic Retinopathy Market Size, Status and Forecast 2019-2025
出版日: 2019年07月09日 ページ情報: 英文 114 Pages
概要

当レポートでは、世界の糖尿病性網膜症の治療薬の市場について分析し、業界の基本構造や背景事情・最新情勢、全体的な市場規模の動向見通し、種類別・用途別および地域別の詳細動向、企業別の市場シェア構造、主要企業のプロファイル、今後の市場成長の可能性・方向性などを調査しております。

第1章 分析概要

  • 分析範囲
  • 主な市場区分
  • 分析対象企業
  • 市場分析:種類別
    • 市場規模・成長率:種類別 (通算12年間分)
    • レーザー手術
    • コルチコステロイドの注入
    • 抗VEGF (血管内皮増殖因子) 薬の目への注入
    • 網膜硝子体手術
  • 市場分析:用途別
    • 市場規模・成長率:用途別 (通算12年間分)
    • 病院
    • 診療所・試験室
    • その他
  • 分析目的
  • 分析対象期間

第2章 世界市場の成長動向

  • 糖尿病性網膜症:市場規模
  • 糖尿病性網膜症:市場成長率の動向、地域別
    • 地域別の市場規模 (通算12年間分)
    • 地域別の市場シェア (過去6年間分)
  • 産業動向
    • 市場の主な動向
    • 市場促進要因
    • 市場機会

第3章 主要企業の市場シェア

  • 糖尿病性網膜症の市場規模:メーカー別
    • 市場規模:メーカー別
    • 市場シェア:メーカー別
    • 市場集中度 (上位5社分、HHI指数)
  • 主要企業の本社所在地・活動地域
  • 主要企業の製品/ソリューション/サービス
  • 糖尿病性網膜症市場への参入時期
  • 企業合併・買収 (M&A)/事業拡張計画

第4章 市場データの内訳:種類別・用途別

  • 種類別の市場規模 (過去6年間分)
  • 用途別の市場規模 (過去6年間分)

第5章 米国市場

  • 糖尿病性網膜症の市場規模 (過去6年間分)
  • 国内の主要企業
  • 市場規模:種類別
  • 市場規模:用途別

第6章 欧州市場

第7章 中国市場

第8章 日本市場

第9章 東南アジア市場

第10章 インド市場

第11章 中南米市場

第12章 主要企業のプロファイル

  • Bayer
    • 企業基本データ
    • 企業概略・事業概要
    • 糖尿病性網膜症事業:概略
    • 糖尿病性網膜症事業:市場収益額 (過去6年間分)
    • 近年の主な動向
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals
  • Actavis
  • Alimera Sciences
  • Ampio Pharmaceuticals
  • Antisense Therapeutics
  • BCN Peptides
  • Boehringer Ingelheim
  • Glycadia
  • iCo Therapeutics
  • Isis Pharmaceuticals
  • 興和
  • Lpath
  • Numoda Capital
  • Ohr Pharmaceutical
  • OPKO Health
  • Parexel International
  • Promedior
  • pSivida
  • Quark Pharmaceuticals
  • R-Tech Ueno
  • Sirnaomics
  • ThromboGenics

第13章 市場予測 (今後7年間分)

  • 市場規模の予測値:地域別
  • 米国市場の予測
  • 欧州市場の予測
  • 中国市場の予測
  • 日本市場の予測
  • 東南アジア市場の予測
  • インド市場の予測
  • 中南米市場の予測
  • 市場規模の予測値:製品別 (今後7年間分)
  • 市場規模の予測値:用途別 (今後7年間分)

第14章 アナリストの見解/結論

第15章 付録

図表

List of Tables and Figures

List of Tables and Figures

  • Table Diabetic Retinopathy Key Market Segments
  • Table Key Players Diabetic Retinopathy Covered
  • Table Global Diabetic Retinopathy Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Diabetic Retinopathy Market Size Market Share by Type 2014-2025
  • Figure Laser surgery Figures
  • Table Key Players of Laser surgery
  • Figure Injection of corticosteroids Figures
  • Table Key Players of Injection of corticosteroids
  • Figure Anti-VEGF drugs into the eye Figures
  • Table Key Players of Anti-VEGF drugs into the eye
  • Figure Vitrectomy Figures
  • Table Key Players of Vitrectomy
  • Table Global Diabetic Retinopathy Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospitals Case Studies
  • Figure Clinics and laboratories Case Studies
  • Figure Others Case Studies
  • Figure Diabetic Retinopathy Report Years Considered
  • Table Global Diabetic Retinopathy Market Size 2014-2025 (Million US$)
  • Figure Global Diabetic Retinopathy Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Diabetic Retinopathy Market Size by Regions 2014-2025 (Million US$)
  • Table Global Diabetic Retinopathy Market Size by Regions 2014-2019 (Million US$)
  • Table Global Diabetic Retinopathy Market Share by Regions 2014-2019
  • Figure Global Diabetic Retinopathy Market Share by Regions 2014-2019
  • Figure Global Diabetic Retinopathy Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Diabetic Retinopathy Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Diabetic Retinopathy Market Share by Manufacturers (2014-2019)
  • Figure Global Diabetic Retinopathy Market Share by Manufacturers in 2018
  • Table Global Diabetic Retinopathy Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Diabetic Retinopathy Product/Solution/Service
  • Table Date of Enter into Diabetic Retinopathy Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table Global Diabetic Retinopathy Market Size Share by Type (2014-2019)
  • Figure Global Diabetic Retinopathy Market Size Market Share by Type (2014-2019)
  • Table Global Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table Global Diabetic Retinopathy Market Size Share by Application (2014-2019)
  • Figure Global Diabetic Retinopathy Market Size Market Share by Application (2014-2019)
  • Figure Global Diabetic Retinopathy Revenue Market Share by Application in 2018
  • Figure United States Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table United States Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table United States Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table United States Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table United States Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table United States Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table United States Diabetic Retinopathy Market Share by Application (2014-2019)
  • Figure Europe Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table Europe Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table Europe Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table Europe Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table Europe Diabetic Retinopathy Market Share by Application (2014-2019)
  • Figure China Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table China Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table China Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table China Diabetic Retinopathy Market Size by Type (2014-20189) (Million US$)
  • Table China Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table China Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table China Diabetic Retinopathy Market Share by Application (2014-2019)
  • Figure Japan Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table Japan Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table Japan Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table Japan Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table Japan Diabetic Retinopathy Market Share by Application (2014-2019)
  • Figure Southeast Asia Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table Southeast Asia Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table Southeast Asia Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Diabetic Retinopathy Market Share by Application (2014-2019)
  • Figure India Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table India Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table India Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table India Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table India Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table India Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table India Diabetic Retinopathy Market Share by Application (2014-2019)
  • Figure Central & South America Diabetic Retinopathy Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Diabetic Retinopathy Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Diabetic Retinopathy Market Share (2018-2019)
  • Table Central & South America Diabetic Retinopathy Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Diabetic Retinopathy Market Share by Type (2014-2019)
  • Table Central & South America Diabetic Retinopathy Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Diabetic Retinopathy Market Share by Application (2014-2019)
  • Table Bayer Company Details
  • Table Bayer Revenue in Diabetic Retinopathy Business (2014-2019) (Million US$)
  • Figure Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Bayer Recent Development
  • Table F. Hoffmann-La Roche Company Details
  • Table F. Hoffmann-La Roche Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure F. Hoffmann-La Roche Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table F. Hoffmann-La Roche Recent Development
  • Table Novartis Company Details
  • Table Novartis Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Novartis Recent Development
  • Table Regeneron Pharmaceuticals Company Details
  • Table Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Regeneron Pharmaceuticals Recent Development
  • Table Actavis Company Details
  • Table Actavis Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Actavis Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Actavis Recent Development
  • Table Alimera Sciences Company Details
  • Table Alimera Sciences Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Alimera Sciences Recent Development
  • Table Ampio Pharmaceuticals Company Details
  • Table Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Ampio Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Ampio Pharmaceuticals Recent Development
  • Table Antisense Therapeutics Company Details
  • Table Antisense Therapeutics Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Antisense Therapeutics Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Antisense Therapeutics Recent Development
  • Table BCN Peptides Company Details
  • Table BCN Peptides Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure BCN Peptides Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table BCN Peptides Recent Development
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2014-2019)(Million US$)
  • Figure Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2014-2019)
  • Table Boehringer Ingelheim Recent Development
  • Table Glycadia Company Details
  • Table iCo Therapeutics Company Details
  • Table Isis Pharmaceuticals Company Details
  • Table Kowa Group Company Details
  • Table Lpath Company Details
  • Table Numoda Capital Company Details
  • Table Ohr Pharmaceutical Company Details
  • Table OPKO Health Company Details
  • Table Parexel International Company Details
  • Table Promedior Company Details
  • Table pSivida Company Details
  • Table Quark Pharmaceuticals Company Details
  • Table R-Tech Ueno Company Details
  • Table Sirnaomics Company Details
  • Table ThromboGenics Company Details
  • Table Global Diabetic Retinopathy Market Size by Regions (Million US$) 2019-2025
  • Figure Global Diabetic Retinopathy Market Size Share by Regions (2019-2025)
  • Figure Global Diabetic Retinopathy Market Size Share by Regions in 2025
  • Figure United States Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Figure China Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Figure India Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Diabetic Retinopathy Market Size Forecast (2019-2025)(Million USD)
  • Table Global Diabetic Retinopathy Market Size by Product (2019-2025) (Million US$)
  • Figure Global Diabetic Retinopathy Market Size by Product (2019-2025)
  • Figure Global Diabetic Retinopathy Market Size by Product in 2025
  • Table Global Diabetic Retinopathy Market Size by Application (2019-2025) (Million US$)
  • Figure Global Diabetic Retinopathy Market Size by Application (2019-2025)
  • Figure Global Diabetic Retinopathy Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.

Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.

In 2018, the global Diabetic Retinopathy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Retinopathy development in United States, Europe and China.

The key players covered in this study

  • Bayer
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals
  • Actavis
  • Alimera Sciences
  • Ampio Pharmaceuticals
  • Antisense Therapeutics
  • BCN Peptides
  • Boehringer Ingelheim
  • Glycadia
  • iCo Therapeutics
  • Isis Pharmaceuticals
  • Kowa Group
  • Lpath
  • Numoda Capital
  • Ohr Pharmaceutical
  • OPKO Health
  • Parexel International
  • Promedior
  • pSivida
  • Quark Pharmaceuticals
  • R-Tech Ueno
  • Sirnaomics
  • ThromboGenics

Market segment by Type, the product can be split into

  • Laser surgery
  • Injection of corticosteroids
  • Anti-VEGF drugs into the eye
  • Vitrectomy

Market segment by Application, split into

  • Hospitals
  • Clinics and laboratories
  • Others

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players.
  • To present the Diabetic Retinopathy development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Retinopathy are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Diabetic Retinopathy Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Laser surgery
    • 1.4.3 Injection of corticosteroids
    • 1.4.4 Anti-VEGF drugs into the eye
    • 1.4.5 Vitrectomy
  • 1.5 Market by Application
    • 1.5.1 Global Diabetic Retinopathy Market Share by Application (2014-2025)
    • 1.5.2 Hospitals
    • 1.5.3 Clinics and laboratories
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Diabetic Retinopathy Market Size
  • 2.2 Diabetic Retinopathy Growth Trends by Regions
    • 2.2.1 Diabetic Retinopathy Market Size by Regions (2014-2025)
    • 2.2.2 Diabetic Retinopathy Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Diabetic Retinopathy Market Size by Manufacturers
    • 3.1.1 Global Diabetic Retinopathy Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Diabetic Retinopathy Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
  • 3.2 Diabetic Retinopathy Key Players Head office and Area Served
  • 3.3 Key Players Diabetic Retinopathy Product/Solution/Service
  • 3.4 Date of Enter into Diabetic Retinopathy Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Diabetic Retinopathy Market Size by Type (2014-2019)
  • 4.2 Global Diabetic Retinopathy Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Diabetic Retinopathy Market Size (2014-2019)
  • 5.2 Diabetic Retinopathy Key Players in United States
  • 5.3 United States Diabetic Retinopathy Market Size by Type
  • 5.4 United States Diabetic Retinopathy Market Size by Application

6 Europe

  • 6.1 Europe Diabetic Retinopathy Market Size (2014-2019)
  • 6.2 Diabetic Retinopathy Key Players in Europe
  • 6.3 Europe Diabetic Retinopathy Market Size by Type
  • 6.4 Europe Diabetic Retinopathy Market Size by Application

7 China

  • 7.1 China Diabetic Retinopathy Market Size (2014-2019)
  • 7.2 Diabetic Retinopathy Key Players in China
  • 7.3 China Diabetic Retinopathy Market Size by Type
  • 7.4 China Diabetic Retinopathy Market Size by Application

8 Japan

  • 8.1 Japan Diabetic Retinopathy Market Size (2014-2019)
  • 8.2 Diabetic Retinopathy Key Players in Japan
  • 8.3 Japan Diabetic Retinopathy Market Size by Type
  • 8.4 Japan Diabetic Retinopathy Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Diabetic Retinopathy Market Size (2014-2019)
  • 9.2 Diabetic Retinopathy Key Players in Southeast Asia
  • 9.3 Southeast Asia Diabetic Retinopathy Market Size by Type
  • 9.4 Southeast Asia Diabetic Retinopathy Market Size by Application

10 India

  • 10.1 India Diabetic Retinopathy Market Size (2014-2019)
  • 10.2 Diabetic Retinopathy Key Players in India
  • 10.3 India Diabetic Retinopathy Market Size by Type
  • 10.4 India Diabetic Retinopathy Market Size by Application

11 Central & South America

  • 11.1 Central & South America Diabetic Retinopathy Market Size (2014-2019)
  • 11.2 Diabetic Retinopathy Key Players in Central & South America
  • 11.3 Central & South America Diabetic Retinopathy Market Size by Type
  • 11.4 Central & South America Diabetic Retinopathy Market Size by Application

12 International Players Profiles

  • 12.1 Bayer
    • 12.1.1 Bayer Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Diabetic Retinopathy Introduction
    • 12.1.4 Bayer Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.1.5 Bayer Recent Development
  • 12.2 F. Hoffmann-La Roche
    • 12.2.1 F. Hoffmann-La Roche Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Diabetic Retinopathy Introduction
    • 12.2.4 F. Hoffmann-La Roche Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.2.5 F. Hoffmann-La Roche Recent Development
  • 12.3 Novartis
    • 12.3.1 Novartis Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Diabetic Retinopathy Introduction
    • 12.3.4 Novartis Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.3.5 Novartis Recent Development
  • 12.4 Regeneron Pharmaceuticals
    • 12.4.1 Regeneron Pharmaceuticals Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Diabetic Retinopathy Introduction
    • 12.4.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.4.5 Regeneron Pharmaceuticals Recent Development
  • 12.5 Actavis
    • 12.5.1 Actavis Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Diabetic Retinopathy Introduction
    • 12.5.4 Actavis Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.5.5 Actavis Recent Development
  • 12.6 Alimera Sciences
    • 12.6.1 Alimera Sciences Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Diabetic Retinopathy Introduction
    • 12.6.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.6.5 Alimera Sciences Recent Development
  • 12.7 Ampio Pharmaceuticals
    • 12.7.1 Ampio Pharmaceuticals Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Diabetic Retinopathy Introduction
    • 12.7.4 Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.7.5 Ampio Pharmaceuticals Recent Development
  • 12.8 Antisense Therapeutics
    • 12.8.1 Antisense Therapeutics Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Diabetic Retinopathy Introduction
    • 12.8.4 Antisense Therapeutics Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.8.5 Antisense Therapeutics Recent Development
  • 12.9 BCN Peptides
    • 12.9.1 BCN Peptides Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Diabetic Retinopathy Introduction
    • 12.9.4 BCN Peptides Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.9.5 BCN Peptides Recent Development
  • 12.10 Boehringer Ingelheim
    • 12.10.1 Boehringer Ingelheim Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Diabetic Retinopathy Introduction
    • 12.10.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2014-2019)
    • 12.10.5 Boehringer Ingelheim Recent Development
  • 12.11 Glycadia
  • 12.12 iCo Therapeutics
  • 12.13 Isis Pharmaceuticals
  • 12.14 Kowa Group
  • 12.15 Lpath
  • 12.16 Numoda Capital
  • 12.17 Ohr Pharmaceutical
  • 12.18 OPKO Health
  • 12.19 Parexel International
  • 12.20 Promedior
  • 12.21 pSivida
  • 12.22 Quark Pharmaceuticals
  • 12.23 R-Tech Ueno
  • 12.24 Sirnaomics
  • 12.25 ThromboGenics

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details
Back to Top